Long-Term Assets: The sum of all assets classified as non-current.
abrdn Life Sciences Investors (HQL) had Long-Term Assets of $308.77M for the most recently reported fiscal quarter, ending 2007-09-30.
Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Balance Sheet Financials | |
$0.30M |
|
-- |
|
Long-Term Assets |
$308.77M |
$309.07M |
|
$0.51M |
|
-- |
|
$0.56M |
|
$1.08M |
|
$308.00M |
|
$307.99M |
|
$307.99M |
|
-- |
|
Cash Flow Statement Financials | |
$10.63M |
|
$0.00M |
|
$-10.63M |
|
$0.00M |
|
$0.00M |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |